SeaStar Medical Holding (ICU) EBT (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly EBT came in at -$3.5 million in Q1 2026, up 6.66% YoY from -$3.3 million in Q1 2025, and down 21.14% on a QoQ basis from -$2.9 million in Q4 2025.
SeaStar Medical Holding (ICU) EBT (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of EBT data on file, last reported at -$3.5 million in Q1 2026.
- Quarterly EBT rose 6.66% year-over-year to -$3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.9 million (up 25.18% YoY) and the FY2025 annual result came in at -$12.1 million, up 51.07% from the prior year.
- EBT eased to -$3.5 million in Q1 2026, from -$2.9 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$902000.0 in Q2 2022 to a low of -$12.7 million in Q1 2024.
- A 5-year average of -$4.6 million and a median of -$3.5 million in 2026 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT slumped 708.35% — and 2025, when it soared 70.32%.
- Tracing ICU's EBT over 5 years: stood at -$8.4 million in 2022, then retreated by 12.75% to -$9.5 million in 2023, then jumped by 53.3% to -$4.4 million in 2024, then surged by 34.28% to -$2.9 million in 2025, then slipped by 21.14% to -$3.5 million in 2026.
- The last three EBT figures came in at -$3.5 million (Q1 2026), -$2.9 million (Q4 2025), and -$3.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - | 81.49 Mn |
| 10 | SeaStar Medical Holding | 13.99 Mn | 6.99 Mn | 561,000.00 | -3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.73 Mn |
| Mar 31, 2026 | -3.52 Mn |
| Dec 31, 2025 | -2.90 Mn |
| Sep 30, 2025 | -3.47 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Mar 31, 2025 | -3.77 Mn |
| Dec 31, 2024 | -4.42 Mn |
| Sep 30, 2024 | -4.48 Mn |
| Jun 30, 2024 | -3.23 Mn |
| Mar 31, 2024 | -12.70 Mn |
| Dec 31, 2023 | -9.46 Mn |
| Sep 30, 2023 | -7.23 Mn |
| Jun 30, 2023 | -2.44 Mn |
| Mar 31, 2023 | -7.10 Mn |
| Dec 31, 2022 | -8.39 Mn |
| Sep 30, 2022 | -1.89 Mn |
| Jun 30, 2022 | -902,000.00 |
| Mar 31, 2022 | -1.00 Mn |
| Dec 31, 2021 | -3.69 Mn |
| Sep 30, 2021 | -408,737.00 |